DTL
SAGE

Dynamic Technology Lab’s Sage Therapeutics SAGE Stock Holding History

Dynamic Technology Lab’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-28,549
Closed -$206K – 1302
2024
Q3 		$206K Buy
28,549
+14,340
+101% +$131K 0.02% 865
2024
Q2 		$154K Sell
14,209
-19,774
-58% -$253K 0.02% 828
2024
Q1 		$637K Buy
33,983
+8,122
+31% +$187K 0.07% 507
2023
Q4 		$560K Buy
+25,861
New +$512K 0.06% 552
2023
Q3 		– Sell
-11,120
Closed -$523K – 1279
2023
Q2 		$523K Sell
11,120
-3,756
-25% -$187K 0.07% 487
2023
Q1 		$624K Buy
+14,876
New +$640K 0.06% 550
2022
Q3 		– Sell
-16,680
Closed -$539K – 1469
2022
Q2 		$539K Buy
+16,680
New +$559K 0.06% 545
2021
Q2 		– Sell
-4,658
Closed -$349K – 1477
2021
Q1 		$349K Buy
+4,658
New +$382K 0.04% 741
2020
Q2 		– Sell
-11,646
Closed -$334K – 1290
2020
Q1 		$334K Buy
+11,646
New +$674K 0.07% 541
2019
Q4 		– Sell
-2,222
Closed -$312K – 1252
2019
Q3 		$312K Buy
2,222
+674
+44% +$113K 0.05% 635
2019
Q2 		$283K Buy
+1,548
New +$264K 0.05% 670
2018
Q4 		– Sell
-8,587
Closed -$1.21M – 1264
2018
Q3 		$1.21M Buy
+8,587
New +$1.33M 0.17% 166
2018
Q1 		– Sell
-4,306
Closed -$710K – 1317
2017
Q4 		$710K Buy
+4,306
New +$417K 0.13% 271
2017
Q3 		– Sell
-7,513
Closed -$598K – 1329
2017
Q2 		$598K Buy
7,513
+4,671
+164% +$338K 0.11% 312
2017
Q1 		$202K Buy
+2,842
New +$166K 0.05% 795

Other funds holding SAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Dynamic Technology Lab's SAGE Position: Q4 2024 in Review

Dynamic Technology Lab sold out of Sage Therapeutics (SAGE) in Q4 2024, closing a stake of 28,549 shares — an estimated $206K sold.

Dynamic Technology Lab first reported a position in SAGE in Q1 2017 and held it in 15 quarters. The position peaked at $1.21M in Q3 2018. 177 funds tracked by Wall St. Rank hold SAGE as of Q4 2024.

  • Dynamic Technology Lab reported no remaining Sage Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 28,549 Sage Therapeutics shares in Q4 2024, an estimated $206K.
  • Dynamic Technology Lab first reported a position in Sage Therapeutics in Q1 2017 and held it in 15 quarters.
  • Dynamic Technology Lab's Sage Therapeutics position peaked at $1.21M in Q3 2018.
  • 177 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.